Is there a generic for Adenosine?

Yes. The FDA Orange Book lists 21 approved generic (ANDA) applications for Adenosine, referencing the brand ADENOSCAN. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Adenosine?

ADENOSCAN (NDA 020059, ASTELLAS) is the reference-listed drug, the approved product a generic applicant must show its version is the same as.

What dosage forms of Adenosine are approved?

Adenosine is approved in the following dosage forms: injectable, solution.

FDA Orange Book · active-ingredient family

Adenosine

Adenosine: 2 brands, 21 generics; first approved Oct 30, 1989; generic available.

Generic availableHas discontinued products

Generic status & protection

Generic available: 21 ANDA applications approved.

Brands (NDA)

Generics (ANDA)

Listed patents

Presentations

Brand (NDA) products

Originator applications

ADENOSCANRLD
ASTELLASNDA 02005919952 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
60MG/20ML (3MG/ML) SOLUTION INTRAVENOUS Discontinued —
90MG/30ML (3MG/ML) SOLUTION INTRAVENOUS Discontinued —
ADENOCARDRLD
ASTELLASNDA 0199371989
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
3MG/ML INJECTABLE INJECTION Discontinued —

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
60MG/20ML (3MG/ML)	SOLUTION	INTRAVENOUS	Discontinued	—
90MG/30ML (3MG/ML)	SOLUTION	INTRAVENOUS	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
3MG/ML	INJECTABLE	INJECTION	Discontinued	—

Generic (ANDA) products (21)

Abbreviated applications

ADENOSINE
FRESENIUS KABI USAANDA 2055682018
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
3MG/ML INJECTABLE INJECTION Rx AP
ADENOSINE
GLANDANDA 2067782018
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
3MG/ML INJECTABLE INJECTION Rx AP
ADENOSINE
FRESENIUS KABI USAANDA 07789720172 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
60MG/20ML (3MG/ML) SOLUTION INTRAVENOUS Rx AP
90MG/30ML (3MG/ML) SOLUTION INTRAVENOUS Rx AP
ADENOSINE
EUGIA PHARMAANDA 20533120172 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
60MG/20ML (3MG/ML) SOLUTION INTRAVENOUS Rx AP
90MG/30ML (3MG/ML) SOLUTION INTRAVENOUS Rx AP
ADENOSINE
RISINGANDA 09045020142 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
60MG/20ML (3MG/ML) SOLUTION INTRAVENOUS Rx AP
90MG/30ML (3MG/ML) SOLUTION INTRAVENOUS Rx AP
ADENOSINE
AVET LIFESCIENCESANDA 20231320142 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
60MG/20ML (3MG/ML) SOLUTION INTRAVENOUS Rx AP
90MG/30ML (3MG/ML) SOLUTION INTRAVENOUS Rx AP
ADENOSINE
MYLAN ASIANDA 09021220142 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
60MG/20ML (3MG/ML) SOLUTION INTRAVENOUS Rx AP
90MG/30ML (3MG/ML) SOLUTION INTRAVENOUS Rx AP
ADENOSINE
HOSPIRAANDA 20388320142 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
60MG/20ML (3MG/ML) SOLUTION INTRAVENOUS Discontinued —
90MG/30ML (3MG/ML) SOLUTION INTRAVENOUS Discontinued —
ADENOSINE
PHARMOBEDIENTANDA 0786402014
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
3MG/ML INJECTABLE INJECTION Discontinued —
ADENOSINERS
MEITHEALANDA 07742520132 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
60MG/20ML (3MG/ML) SOLUTION INTRAVENOUS Rx AP
90MG/30ML (3MG/ML) SOLUTION INTRAVENOUS Rx AP
ADENOSINE
WOCKHARDTANDA 0902202009
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
3MG/ML INJECTABLE INJECTION Discontinued —
ADENOSINE
MYLAN LABS LTDANDA 0786862009
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
3MG/ML INJECTABLE INJECTION Rx AP
ADENOSINE
AM REGENTANDA 0900102009
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
3MG/ML INJECTABLE INJECTION Discontinued —
ADENOSINERS
RISINGANDA 0780762008
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
3MG/ML INJECTABLE INJECTION Rx AP
ADENOSINE
TEVA PHARMS USAANDA 0786762008
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
3MG/ML INJECTABLE INJECTION Discontinued —
ADENOSINE
GLAND PHARMA LTDANDA 0772832007
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
3MG/ML INJECTABLE INJECTION Rx AP
ADENOSINE
FRESENIUS KABI USAANDA 0771332005
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
3MG/ML INJECTABLE INJECTION Rx AP
ADENOSINE
HIKMAANDA 0764042004
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
3MG/ML INJECTABLE INJECTION Rx AP
ADENOSINE
HIKMAANDA 0765002004
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
3MG/ML INJECTABLE INJECTION Rx AP
ADENOSINE
HIKMAANDA 0765012004
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
3MG/ML INJECTABLE INJECTION Discontinued —
ADENOSINE
TEVA PHARMS USAANDA 0765642004
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
3MG/ML INJECTABLE INJECTION Discontinued —

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
3MG/ML	INJECTABLE	INJECTION	Rx	AP

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
3MG/ML	INJECTABLE	INJECTION	Rx	AP

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
60MG/20ML (3MG/ML)	SOLUTION	INTRAVENOUS	Rx	AP
90MG/30ML (3MG/ML)	SOLUTION	INTRAVENOUS	Rx	AP

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
60MG/20ML (3MG/ML)	SOLUTION	INTRAVENOUS	Rx	AP
90MG/30ML (3MG/ML)	SOLUTION	INTRAVENOUS	Rx	AP

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
60MG/20ML (3MG/ML)	SOLUTION	INTRAVENOUS	Rx	AP
90MG/30ML (3MG/ML)	SOLUTION	INTRAVENOUS	Rx	AP

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
60MG/20ML (3MG/ML)	SOLUTION	INTRAVENOUS	Rx	AP
90MG/30ML (3MG/ML)	SOLUTION	INTRAVENOUS	Rx	AP

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
60MG/20ML (3MG/ML)	SOLUTION	INTRAVENOUS	Rx	AP
90MG/30ML (3MG/ML)	SOLUTION	INTRAVENOUS	Rx	AP

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
60MG/20ML (3MG/ML)	SOLUTION	INTRAVENOUS	Discontinued	—
90MG/30ML (3MG/ML)	SOLUTION	INTRAVENOUS	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
3MG/ML	INJECTABLE	INJECTION	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
60MG/20ML (3MG/ML)	SOLUTION	INTRAVENOUS	Rx	AP
90MG/30ML (3MG/ML)	SOLUTION	INTRAVENOUS	Rx	AP

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
3MG/ML	INJECTABLE	INJECTION	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
3MG/ML	INJECTABLE	INJECTION	Rx	AP

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
3MG/ML	INJECTABLE	INJECTION	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
3MG/ML	INJECTABLE	INJECTION	Rx	AP

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
3MG/ML	INJECTABLE	INJECTION	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
3MG/ML	INJECTABLE	INJECTION	Rx	AP

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
3MG/ML	INJECTABLE	INJECTION	Rx	AP

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
3MG/ML	INJECTABLE	INJECTION	Rx	AP

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
3MG/ML	INJECTABLE	INJECTION	Rx	AP

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
3MG/ML	INJECTABLE	INJECTION	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
3MG/ML	INJECTABLE	INJECTION	Discontinued	—

Listed patents

Orange Book patent file

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Approval history

FDA approval span

First approval

Oct 30, 1989

37 yr 3 mo ago

Most recent approval

Apr 16, 2018

8 yr 5 mo ago

Approvals span 1989–2018 across 23 FDA applications.

Brand (NDA) 29%

Generic (ANDA) 2191%

Adenosine: frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo